栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/21 | 2,460 | 2,550 | 2,430 | 2,530 | +52.5 | +2.1% | 140,000 |
2018/02/20 | 2,475 | 2,500 | 2,442.5 | 2,477.5 | -10 | -0.4% | 114,600 |
2018/02/19 | 2,450 | 2,490 | 2,437.5 | 2,487.5 | +70 | +2.9% | 118,600 |
2018/02/16 | 2,402.5 | 2,437.5 | 2,375 | 2,417.5 | +97.5 | +4.2% | 263,200 |
2018/02/15 | 2,285 | 2,330 | 2,267.5 | 2,320 | +37.5 | +1.6% | 126,200 |
2018/02/14 | 2,307.5 | 2,322.5 | 2,257.5 | 2,282.5 | -30 | -1.3% | 167,200 |
2018/02/13 | 2,360 | 2,367.5 | 2,297.5 | 2,312.5 | -60 | -2.5% | 253,800 |
2018/02/09 | 2,420 | 2,437.5 | 2,352.5 | 2,372.5 | -132.5 | -5.3% | 199,000 |
2018/02/08 | 2,450 | 2,540 | 2,450 | 2,505 | +85 | +3.5% | 194,400 |
2018/02/07 | 2,515 | 2,525 | 2,420 | 2,420 | +37.5 | +1.6% | 234,000 |
2018/02/06 | 2,530 | 2,530 | 2,345 | 2,382.5 | -197.5 | -7.7% | 290,400 |
2018/02/05 | 2,575 | 2,605 | 2,555 | 2,580 | -15 | -0.6% | 238,600 |
2018/02/02 | 2,540 | 2,610 | 2,540 | 2,595 | +85 | +3.4% | 275,800 |
2018/02/01 | 2,440 | 2,520 | 2,440 | 2,510 | +85 | +3.5% | 228,800 |
2018/01/31 | 2,442.5 | 2,492.5 | 2,422.5 | 2,425 | +5 | +0.2% | 273,000 |
2018/01/30 | 2,427.5 | 2,460 | 2,400 | 2,420 | -17.5 | -0.7% | 309,800 |
2018/01/29 | 2,450 | 2,590 | 2,402.5 | 2,437.5 | -25 | -1% | 1,157,800 |
2018/01/26 | 2,495 | 2,505 | 2,447.5 | 2,462.5 | -57.5 | -2.3% | 352,000 |
2018/01/25 | 2,545 | 2,550 | 2,505 | 2,520 | -20 | -0.8% | 136,400 |
2018/01/24 | 2,595 | 2,600 | 2,530 | 2,540 | -35 | -1.4% | 239,200 |
2018/01/23 | 2,600 | 2,620 | 2,575 | 2,575 | -10 | -0.4% | 167,200 |
2018/01/22 | 2,615 | 2,615 | 2,565 | 2,585 | -30 | -1.1% | 126,400 |
2018/01/19 | 2,570 | 2,625 | 2,565 | 2,615 | +60 | +2.3% | 184,000 |
2018/01/18 | 2,570 | 2,580 | 2,545 | 2,555 | +5 | +0.2% | 151,000 |
2018/01/17 | 2,540 | 2,565 | 2,540 | 2,550 | -5 | -0.2% | 96,200 |
2018/01/16 | 2,585 | 2,600 | 2,545 | 2,555 | -15 | -0.6% | 176,600 |
2018/01/15 | 2,580 | 2,590 | 2,565 | 2,570 | ±0 | ±0% | 121,400 |
2018/01/12 | 2,565 | 2,605 | 2,550 | 2,570 | -20 | -0.8% | 418,000 |
2018/01/11 | 2,660 | 2,675 | 2,580 | 2,590 | -105 | -3.9% | 262,000 |
2018/01/10 | 2,750 | 2,750 | 2,685 | 2,695 | -65 | -2.4% | 154,800 |
2018/01/09 | 2,745 | 2,805 | 2,740 | 2,760 | +15 | +0.5% | 135,400 |
2018/01/05 | 2,750 | 2,760 | 2,715 | 2,745 | +5 | +0.2% | 91,800 |
2018/01/04 | 2,725 | 2,755 | 2,725 | 2,740 | +40 | +1.5% | 85,600 |
2017/12/29 | 2,715 | 2,725 | 2,690 | 2,700 | -5 | -0.2% | 64,400 |
2017/12/28 | 2,740 | 2,770 | 2,700 | 2,705 | -55 | -2% | 80,800 |
2017/12/27 | 2,690 | 2,760 | 2,685 | 2,760 | +60 | +2.2% | 100,800 |
2017/12/26 | 2,715 | 2,760 | 2,695 | 2,700 | -15 | -0.6% | 95,200 |
2017/12/25 | 2,655 | 2,720 | 2,635 | 2,715 | +65 | +2.5% | 122,000 |
2017/12/22 | 2,620 | 2,655 | 2,615 | 2,650 | +10 | +0.4% | 82,800 |
2017/12/21 | 2,615 | 2,645 | 2,605 | 2,640 | +20 | +0.8% | 82,600 |
2017/12/20 | 2,590 | 2,625 | 2,585 | 2,620 | +20 | +0.8% | 96,600 |
2017/12/19 | 2,620 | 2,640 | 2,600 | 2,600 | -50 | -1.9% | 94,800 |
2017/12/18 | 2,635 | 2,675 | 2,625 | 2,650 | +35 | +1.3% | 217,000 |
2017/12/15 | 2,620 | 2,645 | 2,605 | 2,615 | -15 | -0.6% | 127,200 |
2017/12/14 | 2,640 | 2,660 | 2,605 | 2,630 | +25 | +1% | 145,000 |
2017/12/13 | 2,635 | 2,635 | 2,590 | 2,605 | -35 | -1.3% | 193,200 |
2017/12/12 | 2,650 | 2,670 | 2,625 | 2,640 | -10 | -0.4% | 93,600 |
2017/12/11 | 2,690 | 2,690 | 2,640 | 2,650 | +10 | +0.4% | 109,800 |
2017/12/08 | 2,615 | 2,655 | 2,600 | 2,640 | +35 | +1.3% | 146,400 |
2017/12/07 | 2,565 | 2,630 | 2,535 | 2,605 | +65 | +2.6% | 246,200 |
1651~
1700
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
あすかHD | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム